You are here

TalkMed's Q4 net profit dips 19.3% y-o-y on fewer patient visits


CATALIST-listed healthcare provider TalkMed Group - whose chief executive officer (CEO) and main revenue contributor was suspended by the Singapore Medical Council (SMC) last year - saw its fourth-quarter net profit fall 19.3 per cent to S$8.24 million from S$10.22 million a...